China’s Simcere Pharmaceutical Group Sets IPO at 15.6 Million ADS

April 6, 2007 |

1 min read

WASHINGTON, April 5 (Reuters) - China's Simcere Pharmaceutical Group set on Thursday its planned initial public offering at 15.6 million American depositary shares for an estimated $12.50 to $14.50 each.

>>> Discuss This Story

IPO

MORE ON THIS TOPIC

Aggressive obstacle from the boss. Concept illustration. Vector illustration

Obesity

Is Metsera Worth the Fuss?

November 5, 2025

·

4 min read

·

Annalee Armstrong

Business concept illustration of a businessman being pointed by giant fingers

Earnings

Novo Execs Face Skeptical Analysts Amid Metsera Buyout Drama

November 5, 2025

·

5 min read

·

Annalee Armstrong

A businessman hold a ladder, he tried to break through barriers to move forward

Earnings

Pfizer Fields Novo’s $10B Curveball, With Bourla Promising To Fight for Metsera

November 4, 2025

·

5 min read

·

Annalee Armstrong

Money trap and business risks, insurance concept. Vector of greedy businessman running to the bait, another man trying stop him.

Mergers & acquisitions

Novo Ups Ante In Metsera Buyout Drama With $10B Offer, Beating Pfizer’s New Bid

November 4, 2025

·

1 min read

·

Annalee Armstrong